Pasar al contenido principal

MULTI-SCALE PHYSIOLOGY-DRIVEN COMPUTATIONAL TOOLS TO ASSIST IN THE ASSESSMENT AND MANAGEMENT OF CARDIAC DYSFUNCTIONS

DPI2016-75458-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Otros (Other)

Editorial: Safety Pharmacology - Risk Assessment QT Interval Prolongation and Beyond

  • Grandi, E.
  • Morotti, S.
  • Pueyo, E.
  • Rodriguez, B.
The scope of safety pharmacology is to predict whether a drug is likely to cause potentially lethal adverse effects if administered to humans. While safety pharmacology has broadened its interests in recent years to the whole cardiovascular, respiratory, and central nervous systems (and is now extending to other body functions), a major focus since its inception has been assessing drug-induced prolongation in the QT interval—a surrogate biomarker for torsades de pointes (TdP) liability. Because the vast majority of drugs that can cause QT prolongation inhibit hERG channels, current regulatory guidelines concerning cardiac safety recommend that all compounds are evaluated in vitro for their hERG inhibitory potency (Redfern et al., 2003) and in vivo for their ability to cause QT/QTc interval prolongation (Food and Drug Administration, 2005) in an appropriate animal model and in humans. However, it has now become apparent that QT/QTc prolongation and hERG block are an insufficient proxy for TdP risk. While the current approach based on these markers has been successful in terms of preventing TdP risk, this regulatory paradigm might lead to withdrawal from the drug development pipeline and clinical use of potentially safe drugs. There is therefore a crucial need to develop a more accurate assessment of proarrhythmic potential of drugs...
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Otros (Other)

Excitable dynamics in neural and cardiac systems

  • Barrio, R.
  • Coombes, S.
  • Desroches, M.
  • Fenton, F.
  • Luther, S.
  • Pueyo, E.
The application of mathematics, physics and engineering to medical research is continuously growing; interactions among these disciplines have become increasingly important and have contributed to an improved understanding of clinical and biological phenomena, with implications for disease prevention, diagnosis and treatment. This special issue presents examples of this synergy, with a particular focus on the investigation of cardiac and neural excitability. This issue includes 24 original research papers and covers a broad range of topics related to the physiological and pathophysiological function of the brain and the heart. Studies span scales from isolated neurons and small networks of neurons to whole-organ dynamics for the brain and from cardiac subcellular domains and cardiomyocytes to one-dimensional tissues for the heart. This preface is part of the Special Issue on “Excitable Dynamics in Neural and Cardiac Systems”.